CGRP-Targeted Migraine Therapies in Patients ...

In part one of this two-part series, Dr. Stacey Clardy and Dr. John Ney break down the key message neurologists need to understand from this update and offer guidance on how to clearly convey it to patients. Show citation: Ney JP, Steinmetz JD, Anderson-Benge E, et al. US Burden ...  Show more

In part two of this four-part series, Casey Kozak discusses Hover's sign, the most well-known test for FND. Show transcript: Casey Kozak: Welcome back to Neurology Minute. My name is Casey Kozak with Rutgers, and today we're continuing our examination of functional neurological d ...  Show more

Dr. Matthew Barrett talks with Dr. Michael S. Okun about the caution and deliberation needed in understanding Parkinson disease biomarkers. Read the related viewpoint piece in JAMA Neurology. Disclosures can be found at Neurology.org. 

Today I welcome Dr Val to the show the where we talk about a naturopathic approach to mental health and self esteem.

You can find more from Dr Val here:

<a href="https://calendly.com/url?q=https%3A%2F%2Fdrvalfranc.com%2Fabout-dr-val%2F&user_uuid=EFFBOKWFGRE3A ...

Dr. Linda Chu speaks with Dr. Giuseppe Esposito, Dr. Yasar Torres-Yaghi, and Dr. Lydia Wood to explore how the availability of amyloid PET imaging and other advanced neuroimaging techniques is transforming the diagnostic and treatment landscape for neurodegenerative disorders. Sp ...  Show more

<img align="right" border="0" src="https://support.doctorpodcasting.com/media/k2/items/cache/64c0eb8919976c07a27649dc11664619_S.jpg" alt="practical-strategies-in-lipid ...  Show more